Sandoz Aims For $6bn Biosimilar Business By 2030

Sandoz Has A 22% Share Of Global Biosimilars Market At Present

 
• By Dean Rudge
  
Green Pin In Year 2030
Sandoz has ambitions to treble the size of its biosimilar business by 2030 • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products